E. Mastretta

Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants.

P. Gianino, E. Mastretta, P. Longo, 2002, The Journal of hospital infection.

Long-Term Outcomes after Neonatal Hypoxic-Ischemic Encephalopathy in the Era of Therapeutic Hypothermia: A Longitudinal, Prospective, Multicenter Case-Control Study in Children without Overt Brain Damage

L. Vedovelli, E. Cainelli, A. Suppiej, 2021, Children.

Effect of Lactobacillus GG and Breast-feeding in the Prevention of Rotavirus Nosocomial Infection

P. Gianino, E. Mastretta, P. Longo, 2002, Journal of pediatric gastroenterology and nutrition.

Neonatal cutaneous disseminated aspergillosis in a preterm extremely-low-birth-weight infant with favourable outcome at 3-year follow-up: a case report.

M. Mostert, E. Mastretta, P. Manzoni, 2012, Early human development.

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

G. Dimitriou, E. Dempsey, G. Greisen, 2021, BMC Medical Research Methodology.

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

G. Greisen, A. Mathur, M. Fumagalli, 2020, Frontiers in Pediatrics.

[A traumatic brain injury patient: from rehabilitation to social-familial re-integration. Case report focusing on quality of life aspects].

A. Pierobon, E. Mastretta, S. Callegari, 2006, Giornale italiano di medicina del lavoro ed ergonomia.

Cerebral Oximetry Monitoring in Extremely Preterm Infants.

G. Dimitriou, A. Curley, G. Greisen, 2023, The New England journal of medicine.

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants

M. Fumagalli, J. Jakobsen, L. Thabane, 2023, Trials.